Regentis Biomaterials RGNT
NYSE RGNT
$1.51 +0.04 (+2.72%)
As of: Oct 21, 2026 · 1:51 PM EDT

Regentis Biomaterials (RGNT) Enterprise Value (2025 - 2026)

Updated

Regentis Biomaterials' Enterprise Value came in at -$6.95 million for Q2 2026.

Analysis

Regentis Biomaterials (RGNT) Enterprise Value (2025 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Regentis Biomaterials reported Enterprise Value of $2 million; for FY2025, it was -$3.56 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 258.66 Bn 237.68 Bn 4.88 Bn
2 Abbott Laboratories 172.25 Bn 142.68 Bn 7.27 Bn
3 Danaher 163.69 Bn 147.49 Bn 3.61 Bn
4 Intuitive Surgical 152.41 Bn 131.83 Bn 1.96 Bn
5 Medtronic 119.51 Bn 84.76 Bn 6.34 Bn
6 Stryker 113.97 Bn 100.09 Bn 4.50 Bn
7 Boston Scientific 65.25 Bn 60.02 Bn 3.85 Bn
8 Becton Dickinson 53.52 Bn 50.67 Bn 2.32 Bn
9 Edwards Lifesciences 50.90 Bn 34.90 Bn 1.35 Bn
10 Regentis Biomaterials 855,783.43 855,783.43 -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.33 Mn
Dec 31, 2025 27.53 Mn
API Access

Regentis Biomaterials Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=RGNT&period=max&api_key=YOUR_API_KEY